IP Library › Assignment 032685/0158
Patent Assignment
Reel/Frame 032685/0158

Release of Security Interest

Recorded: 2014-04-14 Pages: 47
Assignor
Assignees
MARINA BIOTECH, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
CEQUENT PHARMACEUTICALS, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
MDRNA RESEARCH, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
Covered Properties (202)
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Compositions for Bacterial Mediated Gene Silencing and Methods of Using Same
Pth Formulations and Methods of Use
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Intranasal Administration of Rapid Acting Insulin
Amphoteric Liposome Formulation
Intranasal Administration of Ultra-Rapid Acting Insulin
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Bacterial Mediated Tnf-a Gene Silencing
Bacteria Mediated Gene Silencing
File Conversion in Restricted Process
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Amino Acid Lipids and Uses Thereof
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Lipopeptides for Delivery of Nucleic Acids
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
E. Coli Mediated Gene Silencing of Beta-Catenin
Usirna Complexes
Activity Generating Delivery Molecules
Nucleic Acid Compounds for Inhibiting Survivin Gene Expression Uses Thereof
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Nucleic Acid Compounds with Conformationally Restricted Monomers and Uses Thereof
Nucleic Acid Compounds for Inhibiting FGFR3 Gene Expression and Uses Thereof
Multi-Sirna Compositions for Reducing Gene Expression
Sugar Modified Nucleosides and Oligonucleotides
Patent: 5,681,940 →
Application: 08/333,545 →
Cationic Peptides, Cys-Trp-(Lys)N,for Gene Delivery
Patent: 6,387,700 →
Application: 09/050,811 →
Genetic Inhibition by Double-Stranded Rna
Patent: 6,506,559 →
Application: 09/215,257 →
Novel Nucleosides Having Bicyclic Sugar Moiety
Patent: 6,403,566 →
Application: 09/451,708 →
Self-Aligned Junction Isolation
Patent: 6,403,482 →
Application: 09/605,726 →
Crosslinked Dna Condensate Compositions and Gene Delivery Methods
Patent: 6,770,740 →
Application: 09/615,153 →
Pyrrolo[2,3-D]Pyrimidine Nucleoside Analogs
Patent: 6,831,069 →
Application: 09/797,549 →
Publication: US 2002/0035077
Amphoteric Liposomes and Their Use
Patent: 7,371,404 →
Application: 10/081,617 →
Publication: US 2003/0099697
Novel Nucleosides Having Bicyclic Sugar Moiety
Patent: 6,833,361 →
Application: 10/136,932 →
Publication: US 2003/0028013
Pyrido[2,3-D]Pyrimidine and Pyrimido[4,5-D]Pyrimidine Nucleosides
Patent: 7,081,449 →
Application: 10/221,397 →
Publication: US 2003/0144502
Genetic Inhibition by Double-Stranded Rna
Patent: 7,538,095 →
Application: 10/282,996 →
Publication: US 2003/0056235
Genetic Inhibition by Double-Stranded Rna
Patent: 7,560,438 →
Application: 10/283,190 →
Publication: US 2003/0051263
Genetic Inhibition by Double-Stranded Rna
Patent: 7,622,633 →
Application: 10/283,267 →
Publication: US 2003/0055020
Compositions and Methods for Enhanced Mucosal Delivery of Peptide Yy and Methods for Treating and Preventing Obesity
Patent: 7,166,575 →
Application: 10/322,266 →
Publication: US 2004/0115135
Sterol Derivatives, Liposomes Comprising Sterol Derivatives and Method for Loading Liposomes with Active Substances
Patent: 7,312,206 →
Application: 10/468,652 →
Publication: US 2004/0131666
Amphoteric Sterols and the Use Thereof
Patent: 7,407,947 →
Application: 10/468,654 →
Publication: US 2004/0120997
Components for producing amphoteric liposomes
Application: 10/505,093 →
Publication: US 2005/0164963
Ph-Sensitive Cationic Lipids, and Liposomes and Nanocapsules Containing the Same
Patent: 8,192,753 →
Application: 10/505,107 →
Publication: US 2006/0002991
Serum-Stable Amphoteric Liposomes
Patent: 8,236,770 →
Application: 10/594,553 →
Publication: US 2008/0311181
Compositions and Methods for Enhanced Mucosal Delivery of Y2 Receptor-Binding Peptides and Methods for Treating and Preventing Obesity
Patent: 7,186,691 →
Application: 10/745,069 →
Publication: US 2004/0157777
Compositions and Methods for Enhanced Mucosal Delivery of Y2 Receptor-Binding Peptides and Methods for Treating and Preventing Obesity
Patent: 7,157,426 →
Application: 10/768,288 →
Publication: US 2004/0209807
Compositions and Methods for Enhanced Mucosal Delivery of Y2 Receptor-Binding Peptides and Methods for Treating and Preventing Obesity
Patent: 7,229,966 →
Application: 10/780,325 →
Publication: US 2004/0214772
Compositions and Methods for Enhanced Mucosal Delivery and Non-Infused Administration of Y2 Receptor-Binding Peptides and Methods for Treating and Preventing Obesity
Patent: 7,186,692 →
Application: 10/869,649 →
Publication: US 2005/0002927
Manufacturing Method for Producing Silicon Carbide Crystal Using Source Gases
Patent: 7,112,242 →
Application: 10/872,365 →
Publication: US 2004/0231583
Phage Displayed Trp Cage Ligands
Patent: 7,329,725 →
Application: 10/976,942 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Patent: 7,244,709 →
Application: 11/126,996 →
Publication: US 2005/0276843
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Patent: 7,435,720 →
Application: 11/550,051 →
Publication: US 2007/0167364
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application: 11/576,139 →
Publication: US 2010/0113332
Amphoteric Liposomes
Patent: 7,780,983 →
Application: 11/590,357 →
Publication: US 2007/0252295
Method for Opening Tight Junctions
Patent: 7,696,343 →
Application: 11/624,630 →
Publication: US 2007/0253956
Phage Displayed Cell Binding Peptides
Patent: 7,704,953 →
Application: 11/627,863 →
Publication: US 2007/0197444
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application: 11/744,745 →
Publication: US 2007/0244049
Amphoteric Liposomes and Their Use
Patent: 7,858,117 →
Application: 11/745,003 →
Publication: US 2008/0031937
Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same
Application: 11/793,429 →
Publication: US 2009/0123426
Genetic inhibition by double-stranded RNA
Application: 11/826,385 →
Publication: US 2008/0050342
Genetic Inhibition of Double-Stranded Rna
Patent: 8,283,329 →
Application: 11/905,368 →
Publication: US 2008/0248576
Genetic inhibition by double-stranded RNA
Patent: 8,580,754 →
Application: 11/905,449 →
Publication: US 2008/0081373
Phage Displayed Trp Cage Ligands
Patent: 8,063,178 →
Application: 11/955,207 →
Publication: US 2008/0096769
Lipids and Lipid Assemblies Comprising Transfection Enhancer Elements
Patent: 8,193,246 →
Application: 12/004,154 →
Publication: US 2008/0306153
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 12/039,650 →
Publication: US 2008/0286866
Nucleic Acid Compounds for Inhibiting Erbb Gene Expression and Uses Thereof
Application: 12/039,658 →
Publication: US 2008/0287383
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Application: 12/039,662 →
Publication: US 2008/0293136
Nucleic Acid Compounds for Inhibiting Apob Gene Expression and Uses Thereof
Application: 12/039,668 →
Publication: US 2008/0299659
Amphoteric Liposome Formulation
Patent: 8,367,628 →
Application: 12/085,893 →
Publication: US 2009/0220584
Amino Acid Lipids and Uses Thereof
Patent: 7,939,505 →
Application: 12/114,284 →
Publication: US 2008/0317839
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Patent: 8,299,236 →
Application: 12/206,165 →
Publication: US 2009/0042298
Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances
Application: 12/225,030 →
Publication: US 2012/0021042
Compositions for Enhanced Epithelial Permeation of Neuropeptide Y for Treating Obesity
Patent: 7,863,245 →
Application: 12/234,547 →
Publication: US 2009/0118158
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Application: 12/376,205 →
Publication: US 2009/0325860
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application: 12/445,575 →
Publication: US 2010/0129460
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Patent: 9,074,205 →
Application: 12/445,868 →
Publication: US 2010/0209487
Construction and Use of Transfection Enhancer Elements
Application: 12/448,452 →
Publication: US 2010/0022621
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Patent: 8,314,227 →
Application: 12/515,403 →
Publication: US 2010/0056768
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 12/528,508 →
Publication: US 2010/0047909
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 12/528,619 →
Publication: US 2010/0112687
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 12/528,786 →
Publication: US 2010/0015706
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 12/529,011 →
Publication: US 2010/0041140
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 12/529,138 →
Publication: US 2010/0055782
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Application: 12/529,302 →
Publication: US 2010/0055783
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Application: 12/529,532 →
Publication: US 2010/0055784
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 12/552,082 →
Publication: US 2010/0105134
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Application: 12/580,250 →
Publication: US 2010/0112042
Bacterial Mediated Tnf Alpha Gene Silencing
Application: 12/602,883 →
Publication: US 2010/0239546
E. Coli Mediated Gene Silencing of Beta-Catenin
Application: 12/618,401 →
Publication: US 2010/0189691
Bacteria Mediated Gene Silencing
Patent: 9,012,213 →
Application: 12/632,985 →
Publication: US 2010/0092438
Intranasal Administration of Rapid Acting Insulin
Application: 12/672,478 →
Publication: US 2010/0210506
Amphoteric Liposomes Comprising Neutral Lipids
Application: 12/682,703 →
Publication: US 2010/0330154
Phage Displayed Cell Binding Peptides
Patent: 7,772,189 →
Application: 12/701,397 →
Publication: US 2010/0137225
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application: 12/726,308 →
Publication: US 2010/0184688
Gras Composition for Intranasal Delivery of Parathyroid Hormone
Application: 12/726,315 →
Publication: US 2010/0166811
Lipopeptides for Delivery of Nucleic Acids
Application: 12/750,622 →
Publication: US 2010/0240731
Amphoteric liposomes
Application: 12/806,342 →
Publication: US 2011/0293695
Amphoteric liposomes
Patent: 9,066,867 →
Application: 12/807,707 →
Publication: US 2011/0076322
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Patent: 8,940,857 →
Application: 12/870,989 →
Publication: US 2010/0316707
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 13/057,741 →
Publication: US 2011/0236972
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Application: 13/057,743 →
Publication: US 2011/0136233
Amino Acid Lipids and Uses Thereof
Patent: 8,501,824 →
Application: 13/076,158 →
Publication: US 2011/0177160
Una Oligomer Structures for Therapeutic Agents
Patent: 9,340,789 →
Application: 13/130,032 →
Publication: US 2011/0313020
Compositions for Bacterial Mediated Gene Silencing and Methods of Using Same
Patent: 9,181,546 →
Application: 13/196,436 →
Publication: US 2012/0093773
Components for Producing Amphoteric Liposomes
Patent: 8,580,297 →
Application: 13/291,650 →
Publication: US 2012/0100205
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Patent: 9,993,425 →
Application: 13/314,080 →
Publication: US 2012/0094903
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 13/327,545 →
Publication: US 2013/0011922
Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
Patent: 9,283,186 →
Application: 13/350,137 →
Publication: US 2012/0135065
Amphoteric Liposomes Comprising Imino Lipids
Application: 13/378,484 →
Publication: US 2012/0237589
Protein-free formulation of peptide YY suitable for intranasal administration
Application: 60/493,226 →
Nanoparticles for delivery of nucleic acids and stable double-stranded RNA
Application: 60/497,740 →
Protein-free formulation of peptide YY suitable for intranasal administration
Application: 60/501,170 →
Protein-free formulation of peptide YY suitable for intranasal administration
Application: 60/510,785 →
Phage displayed Trp cage ligands
Application: 60/515,533 →
Protein-free formulation of peptide YY suitable for intranasal administration
Application: 60/517,290 →
Protein-free formulation of peptide YY suitable for intranasal administration
Application: 60/518,812 →
Method for opening the tight junctions in the nasal cavity
Application: 60/529,682 →
Conjugation of a cholesterol moiety to double-stranded RNA or a double-stranded hybrid nucleic acid
Application: 60/564,543 →
Histones complexed or covalently bonded to double-stranded RNA to an RNA/DNA hybrid
Application: 60/568,027 →
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
Application: 60/570,113 →
Polylpeptides complexed or linked to double-stranded RNA or to an RNA/DNA hybrid with a cationic lipid
Application: 60/570,512 →
Polylpeptides complexed or covalently bonded to double-stranded RNA or to an RNA/DNA hybrid
Application: 60/570,513 →
Use of RNA interference to treat rheumatoid arthritis
Application: 60/613,416 →
Systemic delivery of CD40 antisense
Application: 60/625,195 →
Compositions for bacterial mediated gene silencing and methods of using same
Application: 60/637,277 →
Compositions for bacterial mediated gene silencing and methods of using same
Application: 60/651,238 →
Conjugation or complexation of a protein transduction domain and fusogenic polypeptide to a small interfering nucleic acid for use in RNA interference
Application: 60/656,572 →
Compositions and methods for RNA interference to treat rheumatoid arthritis
Application: 60/667,833 →
Serum stable liposomes comprising amphoter II lipid mixtures
Application: 60/717,291 →
Peptide-mediated sirna uptake into cells
Application: 60/727,216 →
Intranasal administration of insulin
Application: 60/728,877 →
Peptide mediated cellular uptake of double stranded RNA
Application: 60/733,664 →
Amphoteric liposome formulation
Application: 60/741,192 →
Phage displayed cell binding peptides
Application: 60/774,496 →
Intranasal administration of rapid acting insulin
Application: 60/778,724 →
Intranasal Administration of a Rapid Acting Insulin Formulation
Application: 60/806,904 →
Intranasal administration of rapid acting insulin
Application: 60/821,525 →
Phage Displayed Cell Binding Peptides
Application: 60/823,894 →
Intranasal Administration of Rapid Acting Insulin
Application: 60/825,876 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application: 60/825,878 →
COMPOSITIONS AND METHODS EMPLOYING GAPPED OR NICKED siRNA MOLECULES
Application: 60/862,027 →
Intranasal Administration of Rapid Acting Insulin
Application: 60/868,703 →
Intranasal Administration of Rapid Acting Insulin
Application: 60/894,130 →
Compositions and Methods of Using Gapped or Nicked Double Stranded Nucleic Acid Molecules
Application: 60/910,393 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/916,131 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 60/932,949 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 60/932,970 →
Bacteria mediated gene silencing
Application: 60/934,751 →
Nucleic Acid Compounds for Inhibiting ERBB4 Gene Expression and Uses Thereof
Application: 60/934,922 →
Nucleic Acid Compounds for Inhibiting Vegfb Gene Expression and Uses Thereof
Application: 60/934,928 →
Compounds for Inhibiting Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,930 →
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 60/934,931 →
Nucleic Acid Compounds for Inhibiting Pgf Gene Expression and Uses Thereof
Application: 60/934,934 →
Nucleic Acid Compounds for Inhibiting ERBB3 Gene Expression and Uses Thereof
Application: 60/934,935 →
Compounds for Inhibiting Tnf Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,940 →
Nucleic Acid Compounds for Inhibiting Figf Gene Expression and Uses Thereof
Application: 60/934,943 →
Nucleic Acid Compounds for Inhibiting Egfr Gene Expression and Uses Thereof
Application: 60/934,945 →
Nucleic Acid Compounds for Inhibiting ERBB2 Gene Expression and Uses Thereof
Application: 60/934,946 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/947,282 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/953,667 →
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application: 60/955,317 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 60/956,093 →
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application: 60/969,136 →
Emulsion Compositions for Interfering Rna and Uses Thereof
Application: 60/972,590 →
Amino Acid Lipids and Uses for Rna Therapeutics
Application: 60/972,653 →
Nucleic Acid Compounds for Inhibiting RAF1 Gene Expression and Uses Thereof
Application: 60/973,397 →
Nucleic Acid Compounds for Inhibiting AKT1 Gene Expression and Uses Thereof
Application: 60/973,398 →
Lipopeptides for Delivery of Interfering Rna Agents
Application: 60/976,894 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 60/988,395 →
Nucleic Acid Compounds for Inhibiting Nras Gene Expression and Uses Thereof
Application: 60/988,400 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 60/988,401 →
Nucleic Acid Compounds for Inhibiting Kras Gene Expression and Uses Thereof
Application: 60/988,402 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 60/989,419 →
Bacteria mediated gene silencing
Application: 61/010,028 →
Nucleic Acid Compounds for Inhibiting AKT2 Gene Expression and Uses Thereof
Application: 61/013,212 →
Nucleic Acid Compounds for Inhibiting AKT3 Gene Expression and Uses Thereof
Application: 61/013,239 →
Nucleic Acid Compounds for Inhibiting WNT3A Gene Expression and Uses Thereof
Application: 61/015,611 →
Dispersion Compositions for Interfering Rna and Uses Thereof
Application: 61/022,571 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 61/086,435 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereo
Application: 61/086,445 →
Compositions and Methods for Liposomal Rna Therapeutics
Application: 61/106,062 →
Bacteria Mediated Gene Silencing
Application: 61/114,610 →
Rna Oligonucleotides and Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/119,624 →
Compositions and Methods for Efficient Delivery of Gene Silencing Therapeutics
Application: 61/167,379 →
Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/252,085 →
Amino Acid-Based Nanoparticle Formulations
Application: 61/258,115 →
Nucleic Acid Compounds for Inhibiting Survivin Gene Expression and Uses Thereof
Application: 61/318,141 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 61/325,757 →
Modified Forms of Nucleic Acid Compounds and Uses Thereof
Application: 61/328,140 →
Multi-Sirna Compositions for Reducing Gene Expression
Application: 61/329,034 →
Modified Forms of Nucleic Acid Compounds and Uses Thereof
Application: 61/467,048 →
Synthesis and Uses of Nucleic Acid Compounds with Conformationally Restricted Monomers
Application: 61/532,056 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 20, 2013
From: MARINA BIOTECH, INC.
To: ARCTURUS THERAPEUTICS, INC.
Reel/Frame 031047/0842 →
Correction by Declaration of Improperly Recorded Conveyance at Reel/Frame 027712/0200 Sep 7, 2017
From: THE CARNEGIE INSTITUTION OF WASHINGTON; THE UNIVERSITY OF MASSACHUSETTS
To: THE CARNEGIE INSTITUTION OF WASHINGTON; THE UNIVERSITY OF MASSACHUSETTS
Reel/Frame 043781/0430 →
Confirmatory License Nov 11, 2018
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047468/0403 →